Peptides

A large amount of experimental therapeutics that are being assessed now are the bioactive
peptides and proteins (Biologics). They're assessed clinically and the research that is done
covers all types of natural bioactive research. They go from basic science to clinical applica-
tions.

Theme research focus on isolating and characterizing the novel bioactive peptides structurally
and functionally. Some of their sources are in nature like the amphibian defense skin secretio-
ns, reptilian, scorpion and insect venoms, and other sources like neuroendocrine tumors.

Broad spectrum antimicrobials, vasoactives, activators/inhibitors of the innate immune system,
neuroactives, angiogenesis, regulators, protease inhibitors, and the smooth muscle modulators
are the biological ones of interest. After they are recognized, the bioactives are then characteri-
zed structurally and functionally.

Most of them are recognized as G-protein-coupled receptors (GPCRs) on ion channels. There
are plenty of drugs that work well as selective inhibitors of important diseased-linked proteases.
A lot of the enzymes are pertinent checkpoints in a variety of the passageways. When they lo-
se control of their active lives, it leads to the aggravation and exacerbation of diseases.

The diseases are cancer, respiratory-related, inflammation, and infections. The infections are re-
ally bacterial, parasitic, and viral. Yes, the making of peptide-based protease inhibitors and their
utilization of activity-based profiling is a top research theme. The theme is still the go-to technolo-
gy used in protease research all around the world.

Some of the researchers have made some of the studies more extensive. The folks make the ac-
tivity-based profiling ways for the identification and characterization of novel protease targets, and
half-quantitative analysis of changes in the celluar proteolytic signatures. Their aim inside the the-
me is to create novel inhibitor strategies that are both the small molecule and macromolecular bio-
logics.

Those are actually for the making of inhibitors directed to cysteine proteases implicated in cancer.
The cysteine proteases are cysteine cathepsins and the ubiquitin-specific proteases. Their second
main aim with the theme is the delineation and inhibition of proteases guilty of the annihilation of h-
ost molecules of innate defense.

Another key aim is the creation of the anti-biofilm strategies that utilizes the metallopeptidase-dire-
cted inhibitors. The 4th top aim is to actually recognize & modulate the channel-activating proteas-
ses, and to recognize and apply the protease inhibitors that derived from venom. The researchers s-
hould get various awards and accolades for the terrific things that they are doing.